With rising fast-food consumption, diabetes, hypertension, and dyslipidemia, India is seeing a significant increase in the burden of obesity. Which Factors are pushing the Gastric Electrical Stimulators Devices in the Asia Pacific?Ī huge patient pool and swift adoption of Western lifestyles resulting in a higher incidence of chronic disorders such as obesity, diabetes, and gastrointestinal disorders in developing nations such as India and China are significant aspects predicted to propel the Asia Pacific gastric electrical stimulators market.ĭuring the forecast timeline, India is expected to be responsible for a sizable share of the Asia Pacific market excluding Japan. The FDA's approval of the launch of the Enterra Therapy System, the only available gastric electrical stimulator system, on humanitarian device exemption grounds is also driving growth in the United States.
The efforts of organizations such as The American College of Gastroenterology and the National Institute for Health and Care Excellence (NICE), which have granted guidelines listing gastric electrical stimulators as a safe and reliable therapeutic approach for gastroparesis, are also expected to fuel the expansion of the gastric electrical stimulators market in North America. North America is accounting for a market share of 57.1% of the global gastric electrical stimulators market. North America represents the most appealing market for gastric electrical stimulators and is projected to continue to conquer the market in the coming years due to regulatory support and increased awareness of gastroparesis among medical professionals. How Will Growth Unfold in the North America Gastric Electrical Stimulators Market? Two unipolar intramuscular probes and a neurostimulator are used in the gastric electrical stimulator device.
Gastric stimulator skin#
It is a small battery-powered device that is implanted beneath the skin in the lower abdomen. This condition is treated or managed using a gastric electrical stimulator. This condition, which causes malnutrition and dehydration, cannot be addressed with standard medication. This condition causes an overgrowth of bacteria in the small intestine, leading to symptoms such as chronic nausea or vomiting, as well as constipation. Normally, the stomach breaks down solid food into small particles, but during gastroparesis, the food does not proceed into the small intestine and remains in the stomach for longer than usual. Gastroparesis is a condition or disorder that affects the nerves of the stomach and restricts them from performing their normal function. Gastric Electrical Stimulators Market Growth Rate (2022-2032)Ī gastric electrical stimulator is a type of electronic stimulation device that is employed to treat gastroparesis. Gastric Electrical Stimulators Market Revenue Forecast (2032)
Gastric Electrical Stimulators Market Size (2022) The market expansion of gastric electrical stimulators is projected to grow at a robust CAGR of 6.2 % between 20, totaling around US$ 439.9 Million by the end of 2032. The increasing availability of novel high-frequency gastric electrical stimulators, as well as a greater emphasis on the treatment of chronic illnesses such as gastroparesis, are expected to dominate the market. The global gastric electrical stimulators market size is expected to reach a valuation of US$ 227.8 Million in 2022. Gastric Electrical Stimulators Market Outlook (2022-2032)
0 kommentar(er)
